AndroGel 1 recalled over temperature-control failures
- Recall date
- September 8, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- AbbVie Inc. recalls AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pum…
- Recall number
- D-0033-2018
- FDA classification
- Class III
- Brand / firm
- AbbVie Inc.
- Sold / distributed
- AZ
Why it was recalled
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pump actuations, Rx Only, Marketed by: AbbVie Inc., North Chicago, IL 60064 USA. NDC: 0051-8462-33
Get recall alerts
Free email alert whenever AbbVie Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AbbVie Inc.